Scintel stands as a prominent player in the pharmaceutical sector, providing a comprehensive range of products and services to meet diverse client needs. Our portfolio includes the meticulous manufacturing and distribution of Active Pharmaceutical Ingredients (APIs), intermediates, and impurities, serving innovators, formulators, and generic pharmaceutical companies globally. With a strategic focus on being a one-stop solution, we offer Synthetic Pharmaceutical Substances and high-value specialty chemicals. Our expanded service offerings encompass Contract Research and Manufacturing Services (CRAMS), Contract Development and Manufacturing Organization (CDMO) services, Custom Synthesis, and impurity manufacturing. Backed by competent project management and regulatory support, we ensure seamless execution of operations. Our primary business areas revolve around Bulk Drug APIs and Highly Potent APIs, covering Prostaglandins, Oncology drugs, Hormones, and Peptides. Through our extended services, we aim to unlock global potential, contributing to the pharmaceutical industry’s advancement and enhancing global healthcare outcomes.